Ireland: Multi-Party Actions Bill 2017- A Healthcare Perspective

Last Updated: 11 January 2018
Article by Sinéad Corcoran and Mark Murran


The Multi-Party Actions Bill 2017 (the "2017 Bill") was introduced on 9 November 2017 with the aim of reducing the cost of litigation, providing greater access to the courts and allowing the resources of the Courts to be put to better use.

The 2017 Bill was a direct response to the recent tracker mortgage scandal but has implications far beyond this with the possibility, if enacted, of transforming the way medical negligence cases are currently litigated.

Multi-party actions, also known as class action law suits, are not currently an option under Ireland's legal system. The legislation, if passed, would allow for an individual plaintiff who shares common issues as to law or fact with a larger group to litigate the action on behalf of a larger group.

The 2017 Bill sets out the procedure of proposed multi-party actions and relies heavily on the recommendations of the Law Reform Commission's Paper on the subject in this regard.

Mechanics of the 2017 Bill

Under the 2017 Bill, a potential litigant must first identify whether there already exists a previously certified multi-party action relevant to their application which will be facilitated through consultation with the Courts Service. If no such multi-party action exists then the litigant may bring a motion seeking certification before the President of the High Court and the President of the High Court will then nominate a judge to deal with the certification and all subsequent matters arising in the multi-party action.

The nominated judge, in light of the common or related issues of fact or law arising, will have regard to the following in deciding whether to certify proceedings:

  • Whether there are or is likely to be multiple cases giving rise to multi-party action issues; and
  • Whether a multi-party action offers an appropriate, fair and efficient procedure for the resolution of multi-party actions.

Where a multi-party action is ultimately certified the court will issue a multi-party order which will:

  • Establish a register where all the parties involved are recorded;
  • Specify the multi-party issues which are likely to arise;
  • Specify the criteria for entry onto the register; and
  • Specify an expiry date for entry onto the register.

This order may include directions on the publication of the multi-party action, the referral of relevant cases to the judge for determination and may also specify that after a certain date no party may be removed from the register without the permission of the judge. The judge can give directions to assist the fair, efficient and appropriate resolution of the action.

To be entered on the register, a party must first issue proceedings and then apply to the nominated judge. After the expiry of the date for joining the register, the parties must then endeavour to agree the appointment of a lead solicitor, of which there can be more than one. If the parties fail to agree or the judge fails to approve the lead solicitor, the judge will hear submissions from the different parties.

The judge will direct that a lead case which fairly and adequately represent the interests of all those on the register should be selected by way of a case conference.

Unless ordered otherwise, any judgment given in the lead case will be binding on all proceedings on the register at that time and the extent to which the judgment is binding on proceedings subsequently entered on to the register will be at the discretion of the judge. The costs of the action will be divided equally between everyone on the register and the members of the register will be jointly and severally liable for costs.

Current Law

Currently multi-party litigation occurs by way of 'representative actions' and 'test cases'. The strict requirements of representative actions means they are rarely used and will typically arise only where the class either has a pre-existing relationship with the main party or where the class is relatively small.

As a result, test cases are the preferred method of multi-party litigation in Ireland. The court, using its inherent jurisdiction and the doctrine of precedent, will determine a case that becomes the benchmark against which all other similar cases are measured. A test case suffers from the inherent flaw that it is adjudicated exclusively on its own merits and without regard to the broader class. Furthermore, a test case does not avoid the need for each subsequent plaintiff to file their action which is then processed by the courts in the customary way.

The European Commission published a Recommendation in 2013 on collective redress, inviting Member States to adopt collective redress mechanisms for both injunctive and compensatory relief for breaches of EU law rights which follow a set of basic principles. Whilst not binding it is indicative of the future direction in which Brussels would like Member States to move.

Potential of 2017 Bill

The potential impact of the 2017 Bill on the conduct of medical negligence cases is clear. The current provision for multi-party actions under Irish law does not facilitate the bringing of larger-scale actions by groups of individuals who allege that they have suffered similar injuries at the hands of a single potential defendant (or group of defendants). The introduction of the 2017 Bill would give an option to litigants to use the power of the collective to take otherwise unfeasible cases against participants in the healthcare sector.

A particular example of the potential use of the 2017 Bill in a medical context is the recent suite of cases regarding allegedly defective hip implants. Indeed, these cases were referred to in the Oireachtas debates on the 2017 Bill late last year, indicating the envisaged application of the 2017 Bill to such cases.

Mr. Justice Kevin Cross, as far back as 2015, urged the parties to the litigation to find innovative ways to resolve the disputes in an efficient and effective manner. The overriding goal was that, in the interests of justice for everybody, but particularly for those suing in relation to alleged defective implants, the matter could be resolved quickly.

It remains to be seen whether the 2017 Bill, currently at second stage, will receive cross party political support but what is clear is that without reform the current system will do nothing to help an overheating court system and the public's desire to see easier access to the courts, in the healthcare sphere or otherwise.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions